Enhancement of chemotherapy by manipulation of tumour pH
- PMID: 10362108
- PMCID: PMC2363059
- DOI: 10.1038/sj.bjc.6690455
Enhancement of chemotherapy by manipulation of tumour pH
Abstract
The extracellular (interstitial) pH (pHe) of solid tumours is significantly more acidic compared to normal tissues. In-vitro, low pH reduces the uptake of weakly basic chemotherapeutic drugs and, hence, reduces their cytotoxicity. This phenomenon has been postulated to contribute to a 'physiological' resistance to weakly basic drugs in vivo. Doxorubicin is a weak base chemotherapeutic agent that is commonly used in combination chemotherapy to clinically treat breast cancers. This report demonstrates that MCF-7 human breast cancer cells in vitro are more susceptible to doxorubicin toxicity at pH 7.4, compared to pH 6.8. Furthermore 31P-magnetic resonance spectroscopy (MRS) has shown that the pHe of MCF-7 human breast cancer xenografts can be effectively and significantly raised with sodium bicarbonate in drinking water. The bicarbonate-induced extracellular alkalinization leads to significant improvements in the therapeutic effectiveness of doxorubicin against MCF-7 xenografts in vivo. Although physiological resistance to weakly basic chemotherapeutics is well-documented in vitro and in theory, these data represent the first in vivo demonstration of this important phenomenon.
Similar articles
-
Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents.Biochem Pharmacol. 2003 Oct 1;66(7):1219-29. doi: 10.1016/s0006-2952(03)00468-4. Biochem Pharmacol. 2003. PMID: 14505801
-
Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.Acta Biomater. 2015 Mar;14:115-24. doi: 10.1016/j.actbio.2014.12.001. Epub 2014 Dec 9. Acta Biomater. 2015. PMID: 25498306
-
LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump.Oncogene. 2013 Mar 28;32(13):1682-90. doi: 10.1038/onc.2012.183. Epub 2012 May 14. Oncogene. 2013. PMID: 22580606
-
pH and chemotherapy.Novartis Found Symp. 2001;240:199-211; discussion 265-8. doi: 10.1002/0470868716.ch14. Novartis Found Symp. 2001. PMID: 11727930 Review.
-
pH and therapy of human cancers.Novartis Found Symp. 2001;240:68-80; discussion 80-4, 152-3. doi: 10.1002/0470868716.ch5. Novartis Found Symp. 2001. PMID: 11727937 Review.
Cited by
-
Clinical significance of acidic extracellular microenvironment modulated genes.Front Oncol. 2024 Sep 20;14:1380679. doi: 10.3389/fonc.2024.1380679. eCollection 2024. Front Oncol. 2024. PMID: 39372863 Free PMC article.
-
Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities.J Med Chem. 2024 Aug 22;67(16):14040-14061. doi: 10.1021/acs.jmedchem.4c00912. Epub 2024 Aug 8. J Med Chem. 2024. PMID: 39116273 Free PMC article.
-
Biochemical hallmarks-targeting antineoplastic nanotherapeutics.Bioact Mater. 2024 Jul 2;36:427-454. doi: 10.1016/j.bioactmat.2024.05.042. eCollection 2024 Jun. Bioact Mater. 2024. PMID: 39044728 Free PMC article. Review.
-
Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy.Pharmaceutics. 2024 Jun 10;16(6):787. doi: 10.3390/pharmaceutics16060787. Pharmaceutics. 2024. PMID: 38931908 Free PMC article. Review.
-
Increased V-ATPase activity can lead to chemo-resistance in oral squamous cell carcinoma via autophagy induction: new insights.Med Oncol. 2024 Apr 9;41(5):108. doi: 10.1007/s12032-024-02313-9. Med Oncol. 2024. PMID: 38592406 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
